Pan-Cancer Analysis of the Immunological Role of PDIA5: A Potential Target for Immunotherapy
The aberrant protein disulfide isomerase A5 (PDIA5) expression was relevant to the poor prognosis of patients with human cancers. However, its relationship with the epigenetic and genetic alterations and its effect on tumor immunity is still lacking. In the present study, we comprehensively analyzed...
Main Authors: | Yu Chen, Jialin He, Rui Chen, Zeyu Wang, Ziyu Dai, Xisong Liang, Wantao Wu, Peng Luo, Jian Zhang, Yun Peng, Nan Zhang, Zaoqu Liu, Liyang Zhang, Hao Zhang, Quan Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.881722/full |
Similar Items
-
Pericyte mediates the infiltration, migration, and polarization of macrophages by CD163/MCAM axis in glioblastoma
by: Hao Zhang, et al.
Published: (2022-09-01) -
JMJD8 Is an M2 Macrophage Biomarker, and It Associates With DNA Damage Repair to Facilitate Stemness Maintenance, Chemoresistance, and Immunosuppression in Pan-Cancer
by: Xisong Liang, et al.
Published: (2022-07-01) -
A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy
by: He Li, et al.
Published: (2022-12-01) -
The tertiary lymphoid structure-related signature identified PTGDS in regulating PD-L1 and promoting the proliferation and migration of glioblastoma
by: Wantao Wu, et al.
Published: (2024-01-01) -
Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets
by: Aiyuan Guo, et al.
Published: (2022-10-01)